These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4709955)

  • 1. Salivary immunoglobulins in patients with oropharyngeal and bronchopulmonary carcinoma.
    Mandel MA; Dvorak K; DeCosse JJ
    Cancer; 1973 Jun; 31(6):1408-13. PubMed ID: 4709955
    [No Abstract]   [Full Text] [Related]  

  • 2. Salivary immunoglobulins in patients with oropharyngeal or pulmonary cancer.
    Mandel MA; DeCosse JJ
    Br J Plast Surg; 1974 Apr; 27(2):188-93. PubMed ID: 4857758
    [No Abstract]   [Full Text] [Related]  

  • 3. Salivary and bronchial immunoglobulins in patients with respiratory tract carcinoma.
    Dvorak KJ; Katz RL
    Laryngoscope; 1982 Jan; 92(1):35-7. PubMed ID: 6298514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative determination of immunoglobulins in the saliva. Comparative studies in squamous cell carcinomas of the mouth mucosa].
    Müller A; Müller G; Wittstock C; Braun L; Liebermann B
    Zahn Mund Kieferheilkd Zentralbl; 1976; 64(1):3-6. PubMed ID: 134601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity.
    Tavassoli M; Brunel N; Maher R; Johnson NW; Soussi T
    Int J Cancer; 1998 Oct; 78(3):390-1. PubMed ID: 9766578
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretory immune response in patients with oropharyngeal carcinoma.
    Watanabe T; Iglehart JD; Bolognesi DP
    Ann Otol Rhinol Laryngol; 1983; 92(3 Pt 1):295-9. PubMed ID: 6859748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in salivary immunoglobulin levels after cryosurgery of benign and malignant lesions of the oral cavity].
    Fazio M; Airoldi M; Mastromatteo V; Negri L; Biglino G; Furlani D
    Boll Soc Ital Biol Sper; 1982 Apr; 58(7):425-31. PubMed ID: 7082481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma.
    Kelly B; Levy JG
    Br J Cancer; 1977 Jun; 35(6):828-33. PubMed ID: 871369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of the IGA levels of serum and whole saliva with the progression of oral cancer.
    Brown AM; Lally ET; Frankel A; Harwick R; Davis LW; Rominger CJ
    Cancer; 1975 Apr; 35(4):1154-62. PubMed ID: 803867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Class specific antibody response and in-vitro lymphocyte stimulation after primary immunization with Helix pomatia hemocyanin.
    Jansen HM; The TH; Orie NG
    Chest; 1979 Feb; 75(2 Suppl):282-8. PubMed ID: 312185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for an adenovirus etiology of human oral and pharyngeal tumors.
    Rangan SR; Mukherjee AL; Bang FB
    Int J Cancer; 1968 Nov; 3(6):819-28. PubMed ID: 4894384
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum and salivary immunoglobulin level in precancerous diseases of the oral mucosa].
    Brusenina ND; Rudakova AT
    Stomatologiia (Mosk); 1982; 61(5):30-4. PubMed ID: 6959387
    [No Abstract]   [Full Text] [Related]  

  • 14. [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
    Fiorella R; Di Nicola V; Giannubilo C; Facondo M
    Acta Otorhinolaryngol Ital; 1988; 8(2):133-6. PubMed ID: 3188902
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of the secretory immune system to bronchogenic carcinoma of the lung.
    Iglehart JD; Montelaro RC; Bolognesi DP; Sabiston DC; Wolfe WG
    Surg Forum; 1979; 30():118-9. PubMed ID: 231845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumour-specific antibodies in the regional lymph nodes of patients with lung cancer (author's transl)].
    Matsubara Y; Funatsu T; Hatakenaka R; Kuwabara M; Taki T; Miyamoto Y; Kosaba S; Ninomiya K; Ikeda S
    Prax Klin Pneumol; 1980 Sep; 34(9):524-32. PubMed ID: 6256724
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative determination of salivary immunoglobulins as a method of studying local immunity in malignant neoplasms of the oral cavity].
    Brusenina ND
    Stomatologiia (Mosk); 1976; 55(4):34-7. PubMed ID: 828782
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered expression of human monocyte Fc receptors in malignant disease.
    Rhodes J
    Nature; 1977 Jan; 265(5591):253-5. PubMed ID: 189209
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum immunoglobulin levels and survival rates in bronchogenic carcinoma patients.
    Plesnicar S; Rudolf Z
    Neoplasma; 1979; 26(6):721-8. PubMed ID: 542209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of coexistence of bronchogenic carcinoma and active pulmonary tuberculosis (author's transl)].
    Komatsu H; Ishizuka Y; Yoneda R
    Kekkaku; 1981 Feb; 56(2):49-55. PubMed ID: 7265603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.